Literature DB >> 30254213

Fetal fraction evaluation in non-invasive prenatal screening (NIPS).

Matthew S Hestand1,2, Mark Bessem1, Peter van Rijn1, Renee X de Menezes3, Daoud Sie1, Ingrid Bakker1, Elles M J Boon1, Erik A Sistermans1, Marjan M Weiss4.   

Abstract

An important factor in quality control of non-invasive prenatal screening (NIPS) or testing (NIPT) is a sufficient percentage of fetal DNA to avoid false-negative results. Here we evaluate 14,379 shallow whole-genome sequenced diagnostic NIPS samples, as well as negative controls, for both technical and biological factors that can influence fetal fraction and its assessment. Technically, bioinformatics analyses can have a profound impact on fetal fraction determination. We found best performance for fetal fraction determination with the Y chromosome based tool DEFRAG for male fetuses and the count based tool SeqFF for female fetuses. Biologically, gestational age of up to 21 weeks and maternal age had no influence on fetal fraction, while an increase in weight and BMI had a negative influence on fetal fraction. While a trend was observed, no statistically significant difference in fetal fraction was found between trisomy and normal samples. Overall, these results confirm the influence of biological factors and give insight into technical factors that can affect fetal fractions in NIPS.

Mesh:

Year:  2018        PMID: 30254213      PMCID: PMC6336813          DOI: 10.1038/s41431-018-0271-7

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  20 in total

1.  Size distributions of maternal and fetal DNA in maternal plasma.

Authors:  K C Allen Chan; Jun Zhang; Angela B Y Hui; Nathalie Wong; Tze K Lau; Tse N Leung; Kwok-Wai Lo; Dolly W S Huang; Y M Dennis Lo
Journal:  Clin Chem       Date:  2004-01       Impact factor: 8.327

2.  Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma.

Authors:  Eric Wang; Annette Batey; Craig Struble; Thomas Musci; Ken Song; Arnold Oliphant
Journal:  Prenat Diagn       Date:  2013-05-09       Impact factor: 3.050

3.  Cell-free fetal DNA testing in singleton IVF conceptions.

Authors:  Timothy J Lee; Daniel L Rolnik; Melody A Menezes; Andrew C McLennan; Fabricio da Silva Costa
Journal:  Hum Reprod       Date:  2018-04-01       Impact factor: 6.918

4.  Effects of Maternal and Fetal Characteristics on Cell-Free Fetal DNA Fraction in Maternal Plasma.

Authors:  Yi Zhou; Zhongyi Zhu; Ya Gao; Yuying Yuan; Yulai Guo; Lijun Zhou; KaiKai Liao; Jun Wang; Bole Du; Yumei Hou; Zhonglin Chen; Fang Chen; Hongyun Zhang; Cong Yu; Lijian Zhao; T K Lau; Fuman Jiang; Wei Wang
Journal:  Reprod Sci       Date:  2015-05-11       Impact factor: 3.060

5.  Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.

Authors:  R Revello; L Sarno; A Ispas; R Akolekar; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2016-04-25       Impact factor: 7.299

6.  Single Nucleotide Polymorphism-Based Analysis of Cell-Free Fetal DNA in 3000 Cases from Germany and Austria.

Authors:  B Eiben; M Krapp; H Borth; N Kutur; P Kreiselmaier; R Glaubitz; J Deutinger; E Merz
Journal:  Ultrasound Int Open       Date:  2015-06-26

7.  Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics.

Authors:  G Ashoor; A Syngelaki; L C Y Poon; J C Rezende; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2012-12-04       Impact factor: 7.299

8.  Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidies.

Authors:  Irena Hudecova; Daljit Sahota; Macy M S Heung; Yongjie Jin; Wing S Lee; Tak Y Leung; Yuk Ming Dennis Lo; Rossa W K Chiu
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

9.  Calculating the fetal fraction for noninvasive prenatal testing based on genome-wide nucleosome profiles.

Authors:  Roy Straver; Cees B M Oudejans; Erik A Sistermans; Marcel J T Reinders
Journal:  Prenat Diagn       Date:  2016-05-20       Impact factor: 3.050

10.  Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact.

Authors:  Dick Oepkes; G C Lieve Page-Christiaens; Caroline J Bax; Mireille N Bekker; Catia M Bilardo; Elles M J Boon; G Heleen Schuring-Blom; Audrey B C Coumans; Brigitte H Faas; Robert-Jan H Galjaard; Attie T Go; Lidewij Henneman; Merryn V E Macville; Eva Pajkrt; Ron F Suijkerbuijk; Karin Huijsdens-van Amsterdam; Diane Van Opstal; E J Joanne Verweij; Marjan M Weiss; Erik A Sistermans
Journal:  Prenat Diagn       Date:  2016-11-15       Impact factor: 3.050

View more
  15 in total

1.  Most noninvasive prenatal screens failing due to inadequate fetal cell free DNA are negative for trisomy when repeated.

Authors:  Jaime L Lopes; Guilherme S Lopes; Elizabeth A L Enninga; Hutton M Kearney; Nicole L Hoppman; Ross A Rowsey
Journal:  Prenat Diagn       Date:  2020-04-20       Impact factor: 3.050

Review 2.  Calculation of Fetal Fraction for Non-Invasive Prenatal Testing.

Authors:  Matthew Cserhati
Journal:  BioTech (Basel)       Date:  2021-08-09

3.  NiPTUNE: an automated pipeline for noninvasive prenatal testing in an accurate, integrative and flexible framework.

Authors:  Véronique Duboc; David Pratella; Marco Milanesio; John Boudjarane; Stéphane Descombes; Véronique Paquis-Flucklinger; Silvia Bottini
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

4.  Low fetal fraction in cell-free DNA testing is associated with adverse pregnancy outcome: Analysis of a subcohort of the TRIDENT-2 study.

Authors:  Ellis C Becking; Soetinah A M Wirjosoekarto; Peter G Scheffer; Julia V M Huiskes; Marinka J Remmelink; Erik A Sistermans; Caroline J Bax; Janneke M Weiss; Lidewij Henneman; Mireille N Bekker
Journal:  Prenat Diagn       Date:  2021-09-09       Impact factor: 3.242

5.  Clinical Service Delivery of Noninvasive Prenatal Diagnosis by Relative Haplotype Dosage for Single-Gene Disorders.

Authors:  Elizabeth Young; Benjamin Bowns; Amy Gerrish; Michael Parks; Samantha Court; Samuel Clokie; Chipo Mashayamombe-Wolfgarten; Julie Hewitt; Denise Williams; Trevor Cole; Stephanie Allen
Journal:  J Mol Diagn       Date:  2020-06-15       Impact factor: 5.568

6.  Association between low fetal fraction in cell-free DNA testing and adverse pregnancy outcome: A systematic review.

Authors:  Peter G Scheffer; Soetinah A M Wirjosoekarto; Ellis C Becking; Marjan M Weiss; Caroline J Bax; Dick Oepkes; Erik A Sistermans; Lidewij Henneman; Mireille N Bekker
Journal:  Prenat Diagn       Date:  2021-08-18       Impact factor: 3.242

7.  The Level of Free Fetal DNA as Precise Noninvasive Marker for Chromosomal Aneuploidies: First Results from BALTIC Region.

Authors:  Danielius Serapinas; Evelina Boreikaitė; Agnė Bartkevičiūtė; Kristina Norvilaitė; Andrius Narbekovas; Daiva Bartkevičienė
Journal:  Medicina (Kaunas)       Date:  2020-10-30       Impact factor: 2.430

8.  Prenatal screening in the era of non-invasive prenatal testing: a Nationwide cross-sectional survey of obstetrician knowledge, attitudes and clinical practice.

Authors:  Liying Yang; Wei Ching Tan
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-01       Impact factor: 3.007

9.  High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening.

Authors:  Dale Muzzey; Clement S Chu; Noah C Welker; Albert K Lee; Rachel A S Kjolby; Helen Y Wan; Mark R Theilmann; Diana Jeon; James D Goldberg; Kevin R Haas
Journal:  Genet Med       Date:  2020-11-15       Impact factor: 8.822

10.  Total number of reads affects the accuracy of fetal fraction estimates in NIPT.

Authors:  Ieva Miceikaitė; Charlotte Brasch-Andersen; Christina Fagerberg; Martin Jakob Larsen
Journal:  Mol Genet Genomic Med       Date:  2021-03-09       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.